BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15711436)

  • 1. Hypothesized deficiency of guanine-based purines may contribute to abnormalities of neurodevelopment, neuromodulation, and neurotransmission in Lesch-Nyhan syndrome.
    Deutsch SI; Long KD; Rosse RB; Mastropaolo J; Eller J
    Clin Neuropharmacol; 2005; 28(1):28-37. PubMed ID: 15711436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
    Edwards NL; Recker D; Fox IH
    J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families.
    Puig JG; Torres RJ; Mateos FA; Ramos TH; Arcas JM; Buño AS; O'Neill P
    Medicine (Baltimore); 2001 Mar; 80(2):102-12. PubMed ID: 11307586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemical basis of the neurobehavioral abnormalities in the Lesch-Nyhan syndrome: a hypothesis.
    Neychev VK; Mitev VI
    Med Hypotheses; 2004; 63(1):131-4. PubMed ID: 15193365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.
    Fu R; Sutcliffe D; Zhao H; Huang X; Schretlen DJ; Benkovic S; Jinnah HA
    Mol Genet Metab; 2015 Jan; 114(1):55-61. PubMed ID: 25481104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of phytohaemagglutinin stimulated lymphocytes to study effects of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency on polynucleotide and protein synthesis in the Lesch-Nyhan syndrome.
    McKeran RO; Watts RW
    J Med Genet; 1976 Apr; 13(2):91-5. PubMed ID: 933118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling?
    Schretlen DJ; Callon W; Ward RE; Fu R; Ho T; Gordon B; Harris JC; Jinnah HA
    J Inherit Metab Dis; 2016 Jan; 39(1):85-91. PubMed ID: 26067813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome.
    Bakay B; Nissinen E; Sweetman L; Francke U; Nyhan WL
    Pediatr Res; 1979 Dec; 13(12):1365-70. PubMed ID: 523196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome.
    Yeh J; Zheng S; Howard BD
    J Neurosci Res; 1998 Jul; 53(1):78-85. PubMed ID: 9670994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain purines in a genetic mouse model of Lesch-Nyhan disease.
    Jinnah HA; Page T; Friedmann T
    J Neurochem; 1993 Jun; 60(6):2036-45. PubMed ID: 8492116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency: study of 12 cases].
    García Puig J; Mateos FA; Jiménez ML; Arcas J; Miranda ME; Oríz Vázquez J
    Med Clin (Barc); 1994 May; 102(18):681-7. PubMed ID: 8028417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPRT-APRT-deficient mice are not a model for lesch-nyhan syndrome.
    Engle SJ; Womer DE; Davies PM; Boivin G; Sahota A; Simmonds HA; Stambrook PJ; Tischfield JA
    Hum Mol Genet; 1996 Oct; 5(10):1607-10. PubMed ID: 8894695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome.
    Jinnah HA; Gage FH; Friedmann T
    Behav Neurosci; 1991 Dec; 105(6):1004-12. PubMed ID: 1777100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
    Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanine nucleotide depletion induces differentiation and aberrant neurite outgrowth in human dopaminergic neuroblastoma lines: a model for basal ganglia dysfunction in Lesch-Nyhan disease.
    Messina E; Micheli V; Giacomello A
    Neurosci Lett; 2005 Feb; 375(2):97-100. PubMed ID: 15670649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete and partial deficiency of HPRT].
    Ogasawara N
    Nihon Rinsho; 1996 Dec; 54(12):3315-20. PubMed ID: 8976112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine metabolism in female heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Puig JG; Mateos FA; Torres RJ; Buño AS
    Eur J Clin Invest; 1998 Nov; 28(11):950-7. PubMed ID: 9824441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in cellular adhesion of neuroblastoma and fibroblast models of Lesch Nyhan syndrome.
    Stacey NC; Ma MH; Duley JA; Connolly GP
    Neuroscience; 2000; 98(2):397-401. PubMed ID: 10854773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects of tetrahydrobiopterin synthesis and their possible relationship to a disorder of purine metabolism (the Lesch-Nyhan syndrome).
    Watts RW
    Adv Enzyme Regul; 1985; 23():25-58. PubMed ID: 2866676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.